Updated 14 November 2026. Rebuilt as our peptides guide on 30 October, with the October 2026 Poisons Standard, the WADA list, the latest TGA warnings and a status table of the peptides men are being sold. Now with the ABC’s black-market investigation, a plain checklist of what’s illegal and the new infection warning for anyone who injects.
Latest, 14 November 2026: Hepatitis Australia and the Australasian Society of Infectious Diseases have warned that anyone injecting peptides must never share or reuse needles, because shared gear spreads hepatitis B and C (Medical Republic). Needle and syringe programs are seeing more performance and image drugs than ever. What it means if you inject.
10 November 2026: an ABC News investigation has identified more than 50 businesses claiming to sell Australians peptides that aren’t approved for human use, some pushed by social media influencers. It follows TGA testing that found Synedica-branded peptides didn’t contain what their labels claimed. What’s illegal, and who to call.
There are three ways to get a peptide into your body in Australia. One is boring and legal. One has mostly closed. One is where seven Victorians ended up in hospital with acute liver injury.
Here’s the map, without the hedging.
- What they are: short chains of amino acids. Insulin, semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) are peptides
- Legal?: approved peptide medicines are legal with a prescription. BPC-157, TB-500, CJC-1295 and ipamorelin are prescription-only, and possessing them without a prescription is illegal
- ‘Research use only’: doesn’t make a peptide legal to sell, import or use (TGA)
- Selling and advertising: unlawful for unapproved peptides, and that includes influencer and affiliate posts (TGA)
- Sport: BPC-157, TB-500 and the growth-hormone peptides are banned at all times by WADA
- Evidence: BPC-157 and TB-500 rest mostly on animal studies; there are no good human trials
- Before you inject anything: talk to your GP. A vial bought online can contain the wrong drug, the wrong dose or a contaminant

What are peptides?
Peptides are short chains of amino acids, the building blocks of proteins. Your body makes plenty of them, and some of the most important medicines in the world are peptides. Insulin is one. So is semaglutide, the drug in Ozempic and Wegovy (Sport Integrity Australia; TGA). Tirzepatide, sold as Mounjaro, is a modified peptide too (Coskun and colleagues, 2018).

That’s the problem with the word. ‘Peptide’ describes a chemical structure, not a safety rating. An approved pen from a pharmacy and an unlabelled vial from an Instagram seller can both be called peptides. We cover the risks in more detail in are peptides safe?.
Are peptides legal in Australia?
It depends on the peptide and how you got it. All peptide products are regulated as therapeutic goods. The ones on the Australian Register of Therapeutic Goods (ARTG) have been assessed for safety, quality and effectiveness. The rest haven’t, and the TGA names BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 as examples (TGA, April 2026).
Several of the gym favourites are also listed by name in the Poisons Standard. BPC-157, TB-500, thymosin beta-4, CJC-1295, ipamorelin and AOD-9604 are Schedule 4 (prescription-only) medicines and sit in Appendix D, the list of poisons that are illegal to possess without authority, such as a legal prescription (Poisons Standard, October 2026). BPC-157 was added in June 2024 (TGA explanatory statement). State and territory laws add their own controls on possession and supply, so the consequences depend on where you live (TGA).
Selling is where the big penalties are. It is unlawful to import, advertise, manufacture or supply unapproved peptides outside an authorised pathway, and breaches of the Therapeutic Goods Act can bring civil penalties of up to $1.82 million per breach for an individual, $18.2 million for a company, and up to seven years’ jail for criminal offences (TGA, August 2026). In August the TGA and NSW Police seized more than $120,000 of peptides and steroids from two homes linked to an influencer, including retatrutide, CJC-1295 and the Wolverine Stack of BPC-157 and TB-500. The TGA has also put influencers and affiliates on notice that promoting these products can be unlawful advertising (TGA, July 2026).
Common peptides: legal status, WADA and the evidence
BPC-157
Prescription only- Sold for
- Tendon, joint and gut repair
- Legal status in Australia
- Prescription only (Schedule 4); possession without a prescription illegal (Appendix D). Not on the ARTG
- Sport (WADA)
- Banned at all times (S0)
- Human evidence
- Mostly animal studies. Three small uncontrolled human studies, 30 people in total; certainty very low
TB-500 (thymosin beta-4)
Prescription only- Sold for
- Injury recovery
- Legal status in Australia
- Prescription only (Schedule 4); possession without a prescription illegal (Appendix D). Not approved anywhere
- Sport (WADA)
- Banned at all times (S2)
- Human evidence
- No published trials of TB-500 itself. Thymosin beta-4 has been tested as eye drops, wound treatments and in a small safety study
CJC-1295 and ipamorelin
Prescription only- Sold for
- ‘Natural’ growth hormone, muscle, fat loss
- Legal status in Australia
- Prescription only (Schedule 4); possession without a prescription illegal (Appendix D)
- Sport (WADA)
- Banned at all times (S2)
- Human evidence
- CJC-1295 raised growth hormone and IGF-1 in small 2006 volunteer trials. No trial shows muscle or fat-loss benefit in healthy men
GHK-Cu (injected)
Unapproved- Sold for
- Skin, hair, anti-ageing
- Legal status in Australia
- Injectable products are unapproved; the TGA names it in its warnings
- Sport (WADA)
- Not named on the list
- Human evidence
- Mostly lab and skin-care (cream) research; the TGA hasn’t assessed injectable products
Melanotan II
Prescription only- Sold for
- Tanning, libido
- Legal status in Australia
- Prescription only (Schedule 4). Not approved as a tanning agent
- Sport (WADA)
- Not named on the list
- Human evidence
- No approved use. The TGA lists reports of new moles, kidney problems and brain swelling
Retatrutide
Unapproved- Sold for
- Weight loss
- Legal status in Australia
- Unapproved; not approved by any regulator. Anything sold now may be counterfeit
- Sport (WADA)
- Not on the list (Sport Integrity Australia)
- Human evidence
- Large phase 3 trials: up to 22.6% average weight loss at 80 weeks in one. Lilly plans a US filing in early 2027
Semaglutide, tirzepatide
Approved medicine- Sold for
- Diabetes, weight loss
- Legal status in Australia
- Approved prescription medicines (Schedule 4), on the ARTG
- Sport (WADA)
- Not prohibited (on WADA’s monitoring program)
- Human evidence
- Large randomised trials; approved by the TGA
Sources: Poisons Standard October 2026; TGA; WADA Prohibited List 2026; Sport Integrity Australia; studies linked in the text. Checked 30 October 2026.
Tier one: approved peptide medicines, on prescription
Semaglutide and tirzepatide, sold as Ozempic, Wegovy and Mounjaro, are Schedule 4 prescription medicines, approved by the TGA and on the ARTG. A doctor assesses you, writes a script and a real pharmacy dispenses it (healthdirect). You know the dose. You know what’s in the pen. This is the only tier where both of those things are true. On 3 November 2026 the TGA also approved a daily tablet form of Wegovy, which isn’t in pharmacies yet: here’s what we know about the Wegovy pill.
Retatrutide isn’t in this tier. It’s Eli Lilly’s experimental triple-hormone drug, and it has done well in phase 3 trials: in July Lilly reported average weight loss of up to 22.6 per cent at 80 weeks in adults with severe obesity and heart disease, and said it plans to apply to the US Food and Drug Administration in the first quarter of 2027 (Lilly; HCPLive). It is not approved by the TGA or any other regulator (Sport Integrity Australia). Anyone selling you retatrutide now is selling you something with no approved supply chain, and the TGA says it could be counterfeit (TGA).
GLP-1 drugs and muscle
For men, one catch with the approved drugs is what else goes with the fat. Part of the weight lost on GLP-1-based drugs is lean mass: in some trials less than 15 per cent of the total, in others 40 per cent or more. Lean mass isn’t all muscle (it includes organs, bone and water), and reviewers think the muscle change mostly looks in line with the weight lost (Neeland and colleagues, 2024). A 2026 meta-analysis still found more lean-mass loss than in control groups, and its authors recommend pairing the drugs with physical activity and nutritional support (Woźniak and colleagues, 2026). If you’re on one, ask your GP about exercise and nutrition support. And the drugs don’t work equally well for everyone: here’s why some older men lose little weight on Wegovy, and the experimental compound that burned fat without muscle loss in mice.
Tier two: the compounding pathway, mostly closed
For a while, compounding pharmacies made their own versions of GLP-1 drugs for patients with a script: a real, if grey, middle ground. That’s closed. Amendments to the Therapeutic Goods Regulations mean GLP-1 medicines compounded on or after 1 October 2024 can’t be supplied by pharmacists, whatever the dosage form (TGA; Health Minister Mark Butler). Civil and criminal penalties can apply.
Other peptides are a different story. Some doctors do prescribe unapproved peptides, often made up by a compounding pharmacy. A prescription makes possession lawful, but it doesn’t turn the product into a TGA-approved medicine, and the TGA has reminded prescribers and pharmacists of their obligations (TGA). For athletes it’s worse: a compounded peptide is an unregistered medicine, an exemption is unlikely, and using it can still mean a ban (Sport Integrity Australia; see our guide to clean supplements for athletes).

Tier three: Instagram, gym mates and beauticians with a fridge
This is where everyone who isn’t going through a doctor gets their peptides, and it’s where the Victorian liver cases came from. The products are bought online, through friends and through social media accounts (Victorian Department of Health).
Importing doesn’t fix it. The Personal Importation Scheme lets you bring in up to three months’ supply of a medicine for yourself, but only with a valid Australian prescription for anything prescription-only, and only in packaging that clearly identifies the product. The TGA says peptide vials that are unmarked, code-only or missing the ingredient and strength won’t be released, and Border Force can destroy them (TGA, May 2026). ‘For research use only’ printed on a vial changes none of that: the TGA says the disclaimer doesn’t change a product’s status, permit importation or remove advertising and supply obligations (TGA).
That’s the market BPC-157, TB-500, melanotan and retatrutide are being sold into: cash, DMs, gym car parks and, in one case, a beauty clinic. It’s the same wellness pipeline pushing NMN and other anti-ageing supplements.
If you inject: the infection warning
On 13 November, Hepatitis Australia and the Australasian Society of Infectious Diseases put out a joint statement aimed at people injecting peptides for fitness. “Needles, syringes and other injecting equipment must never be shared or reused,” said Lucy Clynes, Hepatitis Australia’s chief executive. “Sharing injecting equipment can transmit blood-borne viruses including hepatitis B and hepatitis C” (Medical Republic).
The numbers back it up. At needle and syringe programs, the share of visits where people reported injecting “anabolic agents and selected hormones” (steroids, peptides, growth hormone and other performance and image drugs) rose from 9% in 2022 to 14% in 2025, according to the Kirby Institute’s national data (2022 report, 2016–2025 report). Most of that group is still steroids, but peptides are counted in it. In Canberra, the needle program run by Directions Health Services told the ABC it has seen an “enormous surge” in peptide users and has had to limit how much equipment each person takes (ABC News).
The statement’s advice, if you’re going to inject anyway:
- Use fresh, sterile equipment for every injection.
- Never share or reuse injecting equipment.
- Sterile needles and syringes are available at most pharmacies. Dispose of used needles safely.
- See a health professional if you have any health concerns.
Red flags: how to spot an illegal peptide seller
- ‘Research use only’ or ‘not for human consumption’ on a product sold to people. It doesn’t make the sale legal.
- No prescription needed for something that is prescription-only in Australia.
- Unmarked vials, code-only labels or no active ingredient and strength on the label. The TGA calls these major red flags.
- Shipped from overseas, or ‘Australian stock’ with no Australian pharmacy behind it.
- Compounded ‘copies’ of Ozempic or Mounjaro. GLP-1 drugs can’t legally be compounded in Australia.
- Retatrutide for sale. It isn’t approved anywhere, and the TGA says any sold outside a clinical trial could be counterfeit.
- Influencer discount codes and before-and-after posts. Advertising prescription and unapproved medicines to the public is generally unlawful.
Sources: TGA, May 2026; TGA, April 2026; TGA, September 2026; Alcohol and Drug Foundation.
The influencer pipeline: what the ABC found
On 7 November an ABC News investigation showed how this market reaches young men. The ABC identified more than 50 businesses claiming to sell Australians peptides that aren’t approved for human use, some promoting them on social media. The sellers often present as legitimate Australian businesses and work through influencer partnerships, while their websites say the products are ‘not for human use’ or ‘research chemicals’. One influencer told the ABC he received free peptides and a commission he says reached $2,000 a week. As the ABC notes, it is illegal to sell, supply or advertise unapproved peptides, and the TGA can fine influencers who promote them.
Don’t trust the paperwork either. Sellers often post certificates of analysis to show their products are pure. The ABC found certificates shown by one seller had been altered, with report numbers removed or hidden, and the European lab named on them confirmed the documents had been edited. The lab’s advice: check any report directly with the lab that issued it. Labels fare no better. When the TGA tested Synedica-branded peptides, three products labelled as containing TB-500 had none detectable (TGA, 5 November 2026; our report).
The TGA says more than 94,500 unapproved peptide products have been seized and destroyed this year. Its acting head, Chris Bedford, told the ABC that since February 2025 authorities have removed more than 10,000 online ads, social media profiles and websites linked to unapproved peptides, and that sellers often reappear under new names. Poisons Information Centre cases and NSW emergency visits are climbing too: the numbers are here.
What’s illegal, what’s prescription-only: the checklist
- Illegal to sell, supply or advertise: unapproved peptides such as BPC-157, TB-500, injectable GHK-Cu, CJC-1295 and retatrutide, outside an authorised pathway. Advertising them to the public is generally unlawful, and that covers websites, social media posts, influencer content and affiliates (TGA, July 2026).
- Prescription-only: BPC-157, TB-500, CJC-1295, ipamorelin and AOD-9604 are Schedule 4 medicines, and possessing them without a prescription is illegal (Poisons Standard). Approved peptide medicines such as insulin, Ozempic, Wegovy and Mounjaro are legal on a script, dispensed by a pharmacy.
- ‘Research use only’ changes nothing. The TGA says the disclaimer doesn’t change a product’s legal status or let it be imported, advertised or supplied (TGA).
- Labels and lab certificates can’t be trusted on unapproved products. The TGA found Synedica products with no detectable TB-500 despite the label, and the ABC found an altered lab report (what the TGA found).
- Got some already? The TGA urges people not to use unapproved peptides. Our read: its advice on the Synedica products is a sound rule for any unapproved vial. Stop using it, take it to a pharmacy for disposal and talk to a health professional if you’re worried (TGA).
- Who to call: unwell after using a peptide? Call the Poisons Information Centre on 13 11 26, 24 hours a day from anywhere in Australia (healthdirect), or 000 in an emergency. Report side effects to the TGA (report a problem) and report sellers or ads that break the rules (report a breach).
Prescribed doesn’t mean approved: a Victorian coroner found actor Richard Norton’s death resulted from complications of unapproved peptides (CJC-1295 and ipamorelin) that a doctor prescribed and a licensed pharmacy compounded, and recommended the TGA review their benefits and risks and consider further restrictions on their use (ABC; more on the finding).
Seven cases, one state, one open question
Victoria’s Chief Health Officer issued a health alert on 19 June about six cases of acute liver injury since January in people who had used an unapproved product labelled retatrutide, and said a contaminant was possibly involved (Victorian health alert). By late August that had risen to seven. Liver specialist Dr Marie Sinclair said a contaminated batch was one possible explanation, but ‘purely a hypothesis’; the TGA’s chief medical adviser, Professor Robyn Langham, said the localised cases suggested ‘a batch problem’ (ABC News).
Canberra Health Services separately confirmed liver damage linked to products sold as retatrutide, without giving a number because the count was low (ABC News). In September the TGA tested another vial sold as retatrutide after a user was hospitalised with uncontrollable vomiting and a torn oesophagus. It contained no retatrutide at all, but semaglutide at about eight times the level in approved products (TGA).
Watch for tiredness, abdominal pain, itchy skin, dark urine, yellow eyes or skin, and easy bruising (Victorian Department of Health). Anyone who has used an unapproved peptide and notices any of that should see a doctor promptly, not wait it out. The Poisons Information Centre takes calls 24/7 on 13 11 26. In an emergency, call 000.
The actual decision
If you want a GLP-1 drug, get it from a doctor, on the register, or don’t take it. The compounded middle ground is gone for anything in the GLP-1 family. For the recovery and ‘natural growth hormone’ peptides, the human evidence isn’t there yet: three tiny uncontrolled studies for BPC-157, none for TB-500 itself. Everything else, every vial with no prescription and no pharmacy label, is tier three, whatever the seller calls it.
If you’re thinking about peptides for an injury, weight or ageing, take it to your GP. Bring the product name and what you’ve been told it does. Australia’s chief medical officer and the TGA have both warned against using unapproved peptide products (Department of Health, June 2026).
Peptides in Australia: FAQ
Are peptides legal in Australia?
Approved peptide medicines such as insulin, Ozempic, Wegovy and Mounjaro are legal with a prescription. Most peptides sold online for muscle, recovery or fat loss are unapproved therapeutic goods, and several of them (BPC-157, TB-500, CJC-1295, ipamorelin, AOD-9604) are prescription-only medicines that are illegal to possess without a prescription (Poisons Standard). Selling, importing or advertising them outside an authorised pathway is unlawful (TGA).
Can I buy peptides online in Australia without a prescription?
Not legally, for most of them. The TGA says most peptide products, including BPC-157 and TB-500, are prescription-only (TGA), so possessing them without a script is illegal, and selling them outside an authorised pathway is unlawful whatever the website says about ‘research use’. Importing needs a valid Australian prescription and properly labelled packaging (TGA). That hasn’t stopped the market: the ABC identified more than 50 businesses claiming to sell Australians peptides not approved for human use (ABC News, November 2026).
Is it legal for influencers to promote peptides?
Usually not. The TGA says advertising unapproved therapeutic goods to Australian consumers is generally unlawful, including social media posts and influencer content, and influencers and affiliates can be held accountable (TGA, July 2026). Breaches of the Therapeutic Goods Act can bring civil penalties of up to $1.82 million per breach for an individual (TGA, August 2026).
Is BPC-157 legal in Australia?
Only with a prescription. BPC-157 has been a Schedule 4 medicine since June 2024, and it’s listed in Appendix D of the Poisons Standard, so possessing it without a prescription is illegal (TGA, 2024). No BPC-157 product is approved by the TGA, and it’s banned in sport at all times.
Can a doctor prescribe peptides in Australia?
Approved peptide medicines, yes. A doctor can also prescribe some unapproved peptides through a compounding pharmacy, but that doesn’t make the product TGA-approved or tested, and GLP-1 drugs can no longer be compounded at all (TGA). Athletes are unlikely to get a therapeutic use exemption for an unregistered medicine (Sport Integrity Australia).
Can I import peptides for personal use?
Only within the Personal Importation Scheme’s rules: a valid Australian prescription for any prescription-only medicine, no more than three months’ supply, and packaging that clearly identifies the product. Unlabelled or code-only vials won’t be released and can be destroyed at the border (TGA; TGA warning, May 2026).
Are peptides banned in sport?
Many are. BPC-157 is banned at all times as a non-approved substance; TB-500, CJC-1295, ipamorelin and other growth-hormone peptides are banned at all times under S2 (WADA Prohibited List 2026). Insulin is also prohibited, though athletes can apply for an exemption. Check any product with Sport Integrity Australia before you use it.
Is retatrutide available in Australia?
Not legally, outside a clinical trial. It isn’t approved by the TGA or any other regulator, and the TGA says any retatrutide sold outside a trial could be counterfeit (TGA). Lilly plans to apply to the US regulator in early 2027 (Lilly).
Sources: Poisons Standard October 2026 and June 2024 explanatory statement; TGA: supplier responsibilities (April 2026), import warning (May 2026), promoters on notice (July 2026), NSW seizure (August 2026), counterfeit retatrutide (September 2026), Synedica testing (November 2026), GLP-1 compounding (2024), Personal Importation Scheme, melanotan; Chief Medical Officer and TGA joint statement (June 2026); Victorian Department of Health alert (June 2026); ABC News (24 August, 29 October and 7 November 2026); Alcohol and Drug Foundation; WADA Prohibited List 2026; Sport Integrity Australia on peptides, BPC-157, thymosin beta-4 and retatrutide; Eli Lilly (July 2026) and HCPLive; Poolton and colleagues (2026), Acta Orthopaedica Belgica; Vasireddi and colleagues (2025), HSS Journal; thymosin beta-4 trials: Sosne and colleagues (2015), Ruff and colleagues (2010); GHK-Cu: Mortazavi and colleagues (2025), BioImpacts; Teichman and colleagues (2006), Journal of Clinical Endocrinology and Metabolism; Villegas Meza and colleagues (2026), JBJS Reviews; Neeland and colleagues (2024) and Woźniak and colleagues (2026); healthdirect: weight loss medicines. Checked 30 October 2026; new material checked 10 November 2026. This article is general information, not medical advice.









